# Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy

> **NCT02155595** · — · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 738 (actual)

## Conditions studied

- Osteoporosis
- Atypical Femoral Fractures
- Prodromal Bone Deterioration

## Interventions

- **OTHER:** 500 without BP treatment
- **OTHER:** 500 with BP treatment

## Key facts

- **NCT ID:** NCT02155595
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-08-31
- **Target enrollment:** 738 (ACTUAL)
- **Last updated:** 2019-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02155595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02155595, "Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02155595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*